Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma

Type of Cancer
Lymphoma

Phase

Division (Location)

Study ID

NCT#

Brief Description
Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.